-

Pharmaceutical Drugs Sales Performance Review Report 2021-2023: Focus on United States, Europe, and Japan - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "A Review of the Best Selling Pharmaceutical Drugs in 2021: 2023 Research Report" report has been added to ResearchAndMarkets.com's offering.

This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies, and company profiles are discussed in detail.

The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe, and Japan.

Report Includes

  • An overview of the best-selling pharmaceutical drugs in 2021
  • Revenue forecast of the top 50 pharmaceutical drugs and assessment of their regulatory landscape
  • Description of the pharmaceutical drugs applications and information on pharmaceutical drugs patents
  • Detailed company profiles of the top 50 pharmaceutical drugs

Key Topics Covered:

Chapter 1 Introduction

1.1 Study Goals and Objectives

1.2 Reasons for Doing this Study

1.3 Scope of Report

1.4 Methodology

1.4.1 Primary Data and Information Gathering

1.4.2 Secondary Data and Information Gathering

1.4.3 Market Revenue Forecasts

1.5 Analyst's Credentials

1.6 Custom Research

1.7 Related Research Reports

Chapter 2 Global Pharmaceutical Drug Market

2.1 Overview

2.2 Key Strategies of Major Pharmaceutical Drugs Manufacturers

2.2.1 Distribution Network

2.2.2 Trends

2.2.3 Mergers and Acquisitions

2.2.4 Recommendations

2.3 Key Developments of the Major Pharmaceutical Drugs Manufacturers

2.3.1 Mergers and Acquisitions

2.3.2 Agreements, Joint Ventures, Expansions, Divestments, and Investments

2.3.3 New Product Launches and Approvals

2.4 Long-Term Outlook

Chapter 3 Regulatory Structure: Pharmaceutical Drug Market

3.1 Regulatory Background

3.2 Regulatory Systems for Biopharmaceuticals by Region

3.2.1 U.S.

3.2.2 Europe

3.2.3 Japan

3.3 Regulatory Systems for Pharmaceuticals by Region

3.3.1 U.S.

3.3.2 Japan

3.3.3 India

3.3.4 Brazil

3.4 Regulations for Vaccines

3.4.1 Current Regulatory Issues for Vaccines

3.4.2 Moderna Vaccine Regulation in the U.K.

3.5 Key Regulatory Updates 2021

3.5.1 Pharmaceuticals

3.5.2 Medical Devices

3.6 Code of Federal Regulations (Cfr)

3.7 Good Manufacturing Practice (Gmp) Compliance

3.8 Establishment Registration

3.9 Drug Registration and Listing

3.10 Local Agent Requirements

3.10.1 Responsibilities of the U.S. Agent

Chapter 4 Pricing and Reimbursement: Pharmaceuticals and Biologics

4.1 Pricing and Reimbursement Background

4.2 Pricing and Reimbursement of Pharmaceuticals and Biologics by Region

4.2.1 U.S.

4.2.2 Europe

4.2.3 Japan

4.3 Pricing and Reimbursement Challenges for Pharmaceuticals

4.3.1 Patented Medicines Price

4.3.2 Prices of Older Drugs

Chapter 5 Company Profiles

  • Abbott
  • Abbvie Inc.
  • Alexion Pharmaceuticals Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Astrazeneca
  • Asahi Kasei Corp.
  • Aurobindo Pharma
  • Bausch Health Companies Inc.
  • Bayer AG
  • Biogen
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Chugai Pharmaceutical Co. Ltd.
  • Csl Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eisai Co. Ltd.
  • Eli Lilly and Co.
  • Endo International plc
  • Gilead Sciences Inc.
  • GlaxoSmithKline plc
  • Grifols S.A.
  • H. Lundbeck A/S
  • Incyte
  • Ipsen Pharma
  • Johnson & Johnson Services Inc.
  • Mallinckrodt plc
  • A. Menarini Industrie Farmaceutiche Riunite S.R.L.
  • Merck & Co. Inc.
  • Merck Kgaa
  • Moderna Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • F. Hoffmann-La Roche Ltd. (Roche)
  • Sanofi
  • Servier Laboratories
  • Shanghai Pharmaceuticals Holding
  • Shionogi & Co. Ltd.
  • China National Pharmaceutical Group Corp. (Sinopharm)
  • Stada Arzneimittel AG
  • Sumitomo Pharma Co. Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Ucb S.A.
  • Vertex Pharmaceuticals Inc.
  • Viatris Inc.
  • Zydus Cadila

For more information about this report visit https://www.researchandmarkets.com/r/iy5jel

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Poland Investment Funds and Asset Management Market Report 2026, Profiles of TFI, Pekao, Santander, PKO, Allianz, Goldman Sachs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investment Funds and Asset Management Market in Poland, 2024-2026" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive overview of the investment funds and asset management sector in Poland. Analysis covers the main pillars of the market, including: mutual funds, insurance, and pension assets. The report also mid-term forecast of key volumes for the period 2025-2027. The data has been presented in a form of horizontal pr...

Europe Data Center Colocation Market Outlook & Forecast Report 2025-2030 Featuring Major Players - Digital Realty, Equinix, NTT DATA, Global Switch, CyrusOne, Ark Data Centres - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Data Center Colocation Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Europe Data Center Colocation Market was valued at USD 9.45 Billion in 2024, and is projected to reach USD 35.73 Billion by 2030, rising at a CAGR of 24.82%. The Europe data center colocation market is expected to witness cumulative investments of approximately $144.03 billion, of which, the Western Europe is slated to ac...

GCC Construction Equipment Market Research Report 2025-2030 Featuring Key Vendors - Caterpillar, Komatsu, Volvo, Hitachi, SANY, XCMG, JCB, Liebherr, Kobelco, and Zoomlion - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GCC Construction Equipment Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering. The GCC Construction Equipment Market was sized at 68,499 Units in 2024, and is projected to reach 94,499 Units by 2030, rising at a CAGR of 5.51%. Governments in the UAE and Saudi Arabia continue to prioritize urban growth and diversification, with Dubai's long-term 2040 Urban Master Plan and the Saudi Vision 2030-linked mega-projects fuelling o...
Back to Newsroom